Tools
Tools
Njoroge, Martin, Mjojob, Patrick, Chirwab, Catherine, Rylance, Sarah, Nightingale, Rebecca, Gordon, Stephen 
ORCID: https://orcid.org/0000-0001-6576-1116, Mortimer, Kevin ORCID: https://orcid.org/0000-0002-8118-8871, Burney, Peter, Balmes, John, Rylance, Jamie ORCID: https://orcid.org/0000-0002-2323-3611, Obasi, Angela ORCID: https://orcid.org/0000-0001-6801-8889, Niessen, Louis ORCID: https://orcid.org/0000-0002-8639-5191 and Devereux, Graham ORCID: https://orcid.org/0000-0002-0024-4887
(2021)
'Changing lung function and associated health-related quality-of-life: A
five-year cohort study of Malawian adults'. EClinicalMedicine, Vol 41, Issue 101166.
|
Text
Njoroge et al 2021.pdf - Published Version Available under License Creative Commons Attribution. Download (570kB) | Preview |
Abstract
Background
In Sub-Saharan Africa cross-sectional studies report a high prevalence of abnormal lung function indicative of chronic respiratory disease. The natural history and health impact of this abnormal lung function in low-and middle-income countries is largely unknown.
Methods
A cohort of 1481 adults representative of rural Chikwawa in Malawi were recruited in 2014 and followed-up in 2019. Respiratory symptoms and health-related quality of life (HRQoL) were quantified. Lung function was measured by spirometry.
Findings
1232 (83%) adults participated; spirometry was available for 1082 (73%). Mean (SD) age 49.5 (17.0) years, 278(23%) had ever smoked, and 724 (59%) were women. Forced expiratory volume in one second (FEV1) declined by 53.4 ml/year (95% CI: 49.0, 57.8) and forced vital capacity (FVC) by 45.2 ml/year (95% CI: 39.2, 50.5) . Chronic airflow obstruction increased from 9.5% (7.6, 11.6%) in 2014 to 17.5% (15.3, 19.9%) in 2019. There was no change in diagnosed asthma or in spirometry consistent with asthma or restriction. Rate of FEV1 decline was not associated with diagnosed Chronic obstructive pulmonary disease (COPD), asthma, or spirometry consistent with asthma, COPD, or restriction. HRQoL was adversely associated with respiratory symptoms (dyspnoea, wheeze, cough), previous tuberculosis, declining FEV1 and spirometry consistent with asthma or restriction. These differences exceeded the minimally important difference.
Interpretation
In this cohort, the increasing prevalence of COPD is associated with the high rate of FEV1 decline and lung function deficits present before recruitment. Respiratory symptoms and sub-optimal lung function are independently associated with reduced HRQoL.
| Item Type: | Article |
|---|---|
| Subjects: | WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries WF Respiratory System > Lungs > WF 600 Lungs |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department Clinical Sciences & International Health > International Public Health Department Clinical Sciences & International Health > Malawi-Liverpool-Wellcome Programme (MLW) |
| Digital Object Identifer (DOI): | https://doi.org/10.1016/j.eclinm.2021.101166 |
| Depositing User: | Debbie Jenkins |
| Date Deposited: | 09 Nov 2021 12:10 |
| Last Modified: | 09 Nov 2021 12:10 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/19212 |
Statistics
Actions (login required)
 |
Edit Item |